212 related articles for article (PubMed ID: 20174463)
1. Healthy human T-Cell Responses to Aspergillus fumigatus antigens.
Chaudhary N; Staab JF; Marr KA
PLoS One; 2010 Feb; 5(2):e9036. PubMed ID: 20174463
[TBL] [Abstract][Full Text] [Related]
2. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.
Hebart H; Bollinger C; Fisch P; Sarfati J; Meisner C; Baur M; Loeffler J; Monod M; Latgé JP; Einsele H
Blood; 2002 Dec; 100(13):4521-8. PubMed ID: 12393638
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus fumigatus proteases, Asp f 5 and Asp f 13, are essential for airway inflammation and remodelling in a murine inhalation model.
Namvar S; Warn P; Farnell E; Bromley M; Fraczek M; Bowyer P; Herrick S
Clin Exp Allergy; 2015 May; 45(5):982-993. PubMed ID: 25270353
[TBL] [Abstract][Full Text] [Related]
4. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.
Knutsen AP; Hutcheson PS; Slavin RG; Kurup VP
Allergy; 2004 Feb; 59(2):198-203. PubMed ID: 14763934
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection.
Sun Z; Zhu P; Li L; Wan Z; Zhao Z; Li R
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3089-96. PubMed ID: 22696051
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
7. Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f 1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice.
Svirshchevskaya E; Frolova E; Alekseeva L; Kotzareva O; Kurup VP
Peptides; 2000 Jan; 21(1):1-8. PubMed ID: 10704713
[TBL] [Abstract][Full Text] [Related]
8. T cell vaccination in mice with invasive pulmonary aspergillosis.
Cenci E; Mencacci A; Bacci A; Bistoni F; Kurup VP; Romani L
J Immunol; 2000 Jul; 165(1):381-8. PubMed ID: 10861075
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA).
Banerjee B; Kurup VP; Greenberger PA; Johnson BD; Fink JN
Clin Exp Allergy; 2001 May; 31(5):761-70. PubMed ID: 11422136
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis.
Banerjee B; Greenberger PA; Fink JN; Kurup VP
Infect Immun; 1998 Nov; 66(11):5175-82. PubMed ID: 9784519
[TBL] [Abstract][Full Text] [Related]
11. Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus.
Banerjee B; Kurup VP; Greenberger PA; Hoffman DR; Nair DS; Fink JN
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):821-7. PubMed ID: 9215251
[TBL] [Abstract][Full Text] [Related]
12. Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis.
Knutsen AP; Mueller KR; Levine AD; Chouhan B; Hutcheson PS; Slavin RG
J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):215-21. PubMed ID: 7914901
[TBL] [Abstract][Full Text] [Related]
13. Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia.
Rivera A; Van Epps HL; Hohl TM; Rizzuto G; Pamer EG
Infect Immun; 2005 Nov; 73(11):7170-9. PubMed ID: 16239511
[TBL] [Abstract][Full Text] [Related]
14. Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen of Aspergillus fumigatus.
Glaser AG; Kirsch AI; Zeller S; Menz G; Rhyner C; Crameri R
Allergy; 2009 Aug; 64(8):1144-51. PubMed ID: 19416144
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.
Knutsen AP; Hutchinson PS; Albers GM; Consolino J; Smick J; Kurup VP
Allergy; 2004 Jan; 59(1):81-7. PubMed ID: 14674938
[TBL] [Abstract][Full Text] [Related]
16. Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10.
Shreiner AB; Murdock BJ; Sadighi Akha AA; Falkowski NR; Christensen PJ; White ES; Hogaboam CM; Huffnagle GB
Infect Immun; 2012 Jan; 80(1):388-97. PubMed ID: 22064716
[TBL] [Abstract][Full Text] [Related]
17. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA.
Kurup VP; Banerjee B; Hemmann S; Greenberger PA; Blaser K; Crameri R
Clin Exp Allergy; 2000 Jul; 30(7):988-93. PubMed ID: 10848921
[TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus.
Strong P; Reid KB; Clark H
Clin Exp Immunol; 2002 Oct; 130(1):19-24. PubMed ID: 12296848
[TBL] [Abstract][Full Text] [Related]
19. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy.
Hemmann S; Nikolaizik WH; Schöni MH; Blaser K; Crameri R
Eur J Immunol; 1998 Apr; 28(4):1155-60. PubMed ID: 9565354
[TBL] [Abstract][Full Text] [Related]
20. Immune response modulation by recombinant peptides expressed in virus-like particles.
Svirshchevskaya EV; Alekseeva L; Marchenko A; Viskova N; Andronova TM; Benevolenskii SV; Kurup VP
Clin Exp Immunol; 2002 Feb; 127(2):199-205. PubMed ID: 11876740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
